Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 07, 2023 12:49 ET | Source: Precipio, Inc.

CORRECTION -- Precipio continues to sign up and onboard HemeScreen™ customers

NEW HAVEN, Conn., March 07, 2023 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Precipio, Inc. (NASDAQ: PRPO), please note that the 5th paragraph should read...
March 07, 2023 12:00 ET | Source: Precipio, Inc.

Precipio continues to sign up and onboard HemeScreen™ customers

NEW HAVEN, Conn., March 07, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) continues to convert its sales pipeline into HemeScreen customers, with an...
July 20, 2022 10:30 ET | Source: Precipio, Inc.

Precipio to distribute HemeScreen® through Fisher Healthcare channel

NEW HAVEN, Conn., July 20, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today announced that it has entered into an agreement with Fisher Healthcare,...
May 10, 2021 10:30 ET | Source: Precipio, Inc.

Precipio Launches New HemeScreen Panel for AML, with an unparalleled 4-hour turnaround-time

NEW HAVEN, Conn., May 10, 2021 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that it has launched a new, four-hour Acute Myeloid Leukemia (AML)...
September 22, 2020 10:30 ET | Source: Precipio, Inc.

Precipio Launches its Proprietary HemeScreen™ AML (Acute Myeloid Leukemia) Molecular Panel

NEW HAVEN, Conn., Sept. 22, 2020 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that it has launched its HemeScreen™ AML (Acute Myeloid...